Artikel mit Open-Access-Mandaten - Ganesh PalapattuWeitere Informationen
Nicht verfügbar: 12
CD44 expression is a feature of prostatic small cell carcinoma and distinguishes it from its mimickers
RA Simon, PA di Sant'Agnese, LS Huang, H Xu, JL Yao, Q Yang, S Liang, ...
Human pathology 40 (2), 252-258, 2009
Mandate: US National Institutes of Health
Assessing the minimum number of lymph nodes needed at radical cystectomy in patients with bladder cancer
U Capitanio, N Suardi, SF Shariat, Y Lotan, GS Palapattu, PJ Bastian, ...
BJU international 103 (10), 1359-1362, 2009
Mandate: Fonds de recherche du Québec - Santé
Reporting standards for the imaging-based diagnosis of renal masses on CT and MRI: a national survey of academic abdominal radiologists and urologists
MS Davenport, EM Hu, AD Smith, H Chandarana, K Hafez, GS Palapattu, ...
Abdominal Radiology 42, 1229-1240, 2017
Mandate: US National Institutes of Health
Standardizing the definition of adverse pathology for lower risk men undergoing radical prostatectomy
MA Kozminski, S Tomlins, A Cole, U Singhal, L Lu, TA Skolarus, ...
Urologic Oncology: Seminars and Original Investigations 34 (9), 415. e1-415. e6, 2016
Mandate: US Department of Veterans Affairs
Mass-like peripheral zone enhancement on CT is predictive of higher-grade (Gleason 4+ 3 and higher) prostate cancer
DI Glazer, MS Davenport, S Khalatbari, RH Cohan, JH Ellis, EM Caoili, ...
Abdominal imaging 40, 560-570, 2015
Mandate: US National Institutes of Health
Certificate of need programs, intensity modulated radiation therapy use and the cost of prostate cancer care
A Khanna, JC Hu, X Gu, PL Nguyen, S Lipsitz, GS Palapattu
The Journal of urology 189 (1), 75-79, 2013
Mandate: US National Institutes of Health
Controversies surrounding lymph node dissection for prostate cancer
GS Palapattu, EA Singer, EM Messing
Urologic Clinics 37 (1), 57-65, 2010
Mandate: US National Institutes of Health
Quality of life in men with metastatic castration-resistant prostate cancer treated with enzalutamide or abiraterone: a systematic review and meta-analysis
KK Ternov, AB Nolsøe, O Bratt, M Fode, H Lindberg, C Kistorp, ...
Prostate Cancer and Prostatic Diseases 24 (4), 948-961, 2021
Mandate: Prostate Cancer Canada
Clinicopathologic characteristics of anterior prostate cancer (APC), including correlation with previous biopsy pathology
MJ Magers, T Zhan, AM Udager, JT Wei, SA Tomlins, AJ Wu, LP Kunju, ...
Medical Oncology 32, 1-11, 2015
Mandate: Howard Hughes Medical Institute
A phase I trial of Neoadjuvant stereotactic body radiotherapy prior to radical prostatectomy for locally advanced prostate cancer
L Hammer, R Jiang, J Hearn, J Lashbrook, A Mitchell, ...
International Journal of Radiation Oncology* Biology* Physics 115 (1), 132-141, 2023
Mandate: US National Institutes of Health
Spatial Transcriptomic Profiling to Characterize the Nature of Peripheral-Versus Transition-zone Prostate Cancer
P Patel, S Nallandhighal, D Scoville, B Cotta, Z Knuth, D Triner, L Tran, ...
European Urology Focus, 2024
Mandate: Robert Wood Johnson Foundation
MP09-08 MOLECULAR DISSECTION OF GRADE PROGRESSION IN MEN ON ACTIVE SURVEILLANCE FOR PROSTATE CANCER
J Tosoian, S Salami, S Nallandhighal, T Jones Jr, S Brockman, F Elkhoury, ...
Journal of Urology 203, e118-e119, 2020
Mandate: US Department of Defense, US National Institutes of Health
Verfügbar: 57
The PSA−/lo prostate cancer cell population harbors self-renewing long-term tumor-propagating cells that resist castration
J Qin, X Liu, B Laffin, X Chen, G Choy, CR Jeter, T Calhoun-Davis, H Li, ...
Cell stem cell 10 (5), 556-569, 2012
Mandate: US National Institutes of Health
The role of sarcosine metabolism in prostate cancer progression
AP Khan, TM Rajendiran, A Bushra, IA Asangani, JN Athanikar, ...
Neoplasia 15 (5), 491-IN13, 2013
Mandate: US National Institutes of Health, Howard Hughes Medical Institute, Doris …
Metabolomic profiling reveals potential markers and bioprocesses altered in bladder cancer progression
N Putluri, A Shojaie, VT Vasu, SK Vareed, S Nalluri, V Putluri, ...
Cancer research 71 (24), 7376-7386, 2011
Mandate: US National Institutes of Health
Frequent PD-L1 expression in primary and metastatic penile squamous cell carcinoma: potential opportunities for immunotherapeutic approaches
AM Udager, TY Liu, SL Skala, MJ Magers, AS McDaniel, DE Spratt, ...
Annals of Oncology 27 (9), 1706-1712, 2016
Mandate: US National Institutes of Health, Howard Hughes Medical Institute
What couples say about their recovery of sexual intimacy after prostatectomy: toward the development of a conceptual model of couples' sexual recovery after surgery for …
D Wittmann, M Carolan, B Given, TA Skolarus, H Crossley, L An, ...
The journal of sexual medicine 12 (2), 494-504, 2015
Mandate: US National Institutes of Health, US Department of Veterans Affairs
Exploring the role of the partner in couples’ sexual recovery after surgery for prostate cancer
D Wittmann, M Carolan, B Given, TA Skolarus, L An, G Palapattu, ...
Supportive Care in Cancer 22, 2509-2515, 2014
Mandate: US National Institutes of Health
Metabolomic profiling reveals a role for androgen in activating amino acid metabolism and methylation in prostate cancer cells
N Putluri, A Shojaie, VT Vasu, S Nalluri, SK Vareed, V Putluri, ...
PloS one 6 (7), e21417, 2011
Mandate: US National Institutes of Health
Transcriptomic heterogeneity in multifocal prostate cancer
SS Salami, DH Hovelson, JB Kaplan, R Mathieu, AM Udager, NE Curci, ...
JCI insight 3 (21), 2018
Mandate: US Department of Defense, US National Institutes of Health
Angaben zur Publikation und Finanzierung werden automatisch von einem Computerprogramm ermittelt